Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.

Autores de IIS La Fe

• 

  Javier Pemán García

  Autor

• Rafael Zaragoza Crespo

  Autor

• Paula Ramírez Galleymore

  Autor

Participantes ajenos a IIS La Fe

• Quindós G
• Alkorta M
• Cuétara MS
• Camarena JJ
• Giménez MJ
• Martín-Mazuelos E
• Linares-Sicilia MJ
• Pontón J
• study group Candida albicans Germ Tube Antibody Detection in Critically Ill Pati

Grupos

• Infecciones Respiratorias

  Investigador Principal

  Raúl Méndez Ocaña

Abstract

Poor outcomes of invasive candidiasis (IC) are associated with the difficulty in establishing the microbiological diagnosis at an early stage. New scores and laboratory tests have been developed in order to make an early therapeutic intervention in an attempt to reduce the high mortality associated with invasive fungal infections. Candida albicans IFA IgG has been recently commercialized for germ tube antibody detection (CAGTA). This test provides a rapid and simple diagnosis of IC (84.4% sensitivity and 94.7% specificity). The aim of this study is to identify the patients who could be benefited by the use of CAGTA test in critical care setting.